Brief: Argenx Q3 Net Income USD 91.41 Million
31/10/2024 06:00
Oct 31 (Reuters) - Argenx Q3 EPS USD 1.39. * Q3 basic EPS USD 1.52 * Q3 operating expenses USD -574.691 million * Q3 total operating income USD 588.878 million
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles